期刊
MITOCHONDRION
卷 49, 期 -, 页码 178-188出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.mito.2019.08.004
关键词
Mitochondrial RNA knockdown; Mitochondrial drug delivery; MITO-porter; Nucleic acids delivery; Nucleic acids medicine
资金
- Ministry of Education, Culture, Sports, Science and Technology of Japanese Government (MEXT) [26282131, 17H02094, 15H12532]
- Japan Society for the Promotion of Science (JSPS) [14J02379]
- Uehara Memorial Foundation
- Akiyama Life Science Foundation
- Grants-in-Aid for Scientific Research [17H02094, 26282131, 14J02379] Funding Source: KAKEN
Mitochondrial gene therapy will be needed to treat mitochondrial diseases. We previously demonstrated mitochondrial gene silencing by the mitochondrial delivery of antisense RNA oligonucleotide (ASO) targeting mtDNA-encoded mRNA using a MITO-Porter, a liposomal nano carrier system designed for mitochondrial delivery. Here, we report on the efficient packaging of ASO in the MITO-Porter via a nanoparticle packaging method, which showed a 10-fold higher packaging efficiency than the conventional method. The constructed carrier showed a decrease in the target mRNA levels and ATP production. These results indicate that such a MITO-Porter has potential for use in therapies designed to regulate mitochondrial function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据